Public market insider buying at HEXO (HEXO)

Public market insider buying at HEXO (T:HEXO)

Vincent Chiara, a Director, acquired 140,500 Common Shares on a direct ownership basis at a price of $2.120 on December 31st, 2019. This represents a $297,860 investment into the company's shares and an account share holdings change of greater than 100%.

HEXO is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Hexo Corp, formerly Hydropothecary Corp, is a Canada-based company that creates and distributes products to serve the Canadian cannabis market. The Company operates with an approximately 300,000 square feet of production capacity. The Company serves the adult-use market under the HEXO brand, while it serves its medical cannabis clients through the Hydropothecary brand. The following are the Company's products under the Hydropothecary brand: Time of Day product line, which includes dried marijuana buds for morning, midday, after dinner and bedtime; Hydrogen (H2) classical medical marijuana line, which includes Papaya Grove, Green Chai and Kush dried marijuana buds, among others; Decarb ready to consume activated marijuana powder; Elixir cannabis oil sublingual spray, as well as Fleur de Lune intimate cannabis oil. HEXO Corp. (HEXO) has below median officer and director direct ownership compared to its small-cap peers in the market, based on our estimate using SEDI data. According to regulatory filings yesterday, one insider has invested a total amount of $297,860.